Table 2.

Aspirin response and pregnancy outcome

Thr/ThrThr/Ala or Ala/AlaP valueAdjusted odds ratio or geometric mean ratio (95% CI); P value
Aspirin response     
PFA-100, follow-up 1 (second tm) 167 (134-202)
n = 19 
152 (126-212)
n = 87 
.90 NS 
PFA-100, follow-up 2 (third tm) 128 (107-175)
n = 19 
151 (126-194)
n = 79 
.14  
Urine thromboxane (second tm) 2761.1 ± 2034.1
n = 6 
1433.8 ± 1186.5
n = 11 
.18 mean ratio, 2.08 (1.66-2.61); P < .001 
Urine thromboxane (third tm) 3982.3 ± 1399.8
n = 7 
1402.9 ± 1019.6
n = 9 
<.001  
Pregnancy outcome n = 22 n = 93  Adjusted Odds ratio 
Hypertensive disorder of pregnancy 4 (18.2) 28 (30.1) .39 NS 
Preterm birth (<37 weeks) 4 (18.2) 13 (14.0) .74 NS 
Intervillous thrombosis  3/18 (16.7) 3/76 (3.9) .08 NC 
Thr/ThrThr/Ala or Ala/AlaP valueAdjusted odds ratio or geometric mean ratio (95% CI); P value
Aspirin response     
PFA-100, follow-up 1 (second tm) 167 (134-202)
n = 19 
152 (126-212)
n = 87 
.90 NS 
PFA-100, follow-up 2 (third tm) 128 (107-175)
n = 19 
151 (126-194)
n = 79 
.14  
Urine thromboxane (second tm) 2761.1 ± 2034.1
n = 6 
1433.8 ± 1186.5
n = 11 
.18 mean ratio, 2.08 (1.66-2.61); P < .001 
Urine thromboxane (third tm) 3982.3 ± 1399.8
n = 7 
1402.9 ± 1019.6
n = 9 
<.001  
Pregnancy outcome n = 22 n = 93  Adjusted Odds ratio 
Hypertensive disorder of pregnancy 4 (18.2) 28 (30.1) .39 NS 
Preterm birth (<37 weeks) 4 (18.2) 13 (14.0) .74 NS 
Intervillous thrombosis  3/18 (16.7) 3/76 (3.9) .08 NC 

PAR4-120 variant with Thr vs Ala. Data are presented as mean ± standard deviation, median (interquartile range), or n (%) as appropriate. Repeat measures (PFA-100 and urinary thromboxane) were compared with generalized estimating equation modeling. The P value for PAR4 genotype is >.20.

NC, not calculable (too few cases); NS, not significant; tm, trimester.

Of those with placental histopathology available.

or Create an Account

Close Modal
Close Modal